References
- Audier H, Fetizon M, Henry Y, Prange T. (1976). Mechanism of fragmentation of oxazole. Org Mass Spectrom 11:1047–1055.
- Atack JR. (2005). The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. Expert Opin Investig Drugs 14:601–618.
- Barnard EA, Skolnick P, Olsen RW, Mohler H, Sieghart W, Biggio G, Braestrup C, Bateson AN, Langer SZ. (1998). International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev 50:291–313.
- Collins I, Moyes C, Davey WB, Rowley M, Bromidge FA, Quirk K, Atack JR, McKernan RM, Thompson SA, Wafford K, Dawson GR, Pike A, Sohal B, Tsou NN, Ball RG, Castro JL. (2002). 3-Heteroaryl-2-pyridones: benzodiazepine site ligands with functional delectivity for alpha 2/alpha 3-subtypes of human GABA(A) receptor-ion channels. J Med Chem 45:1887–1900.
- D’Hulst C, Atack JR, Kooy RF. (2009). The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug Discov Today 14:866–875.
- Graham D, Faure C, Besnard F, Langer SZ. (1996). Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes. Eur Neuropsychopharmacol 6:119–125.
- Johnstone TB, Hogenkamp DJ, Coyne L, Su J, Halliwell RF, Tran MB, Yoshimura RF, Li WY, Wang J, Gee KW. (2004). Modifying quinolone antibiotics yields new anxiolytics. Nat Med 10:31–32.
- Lippa A, Czobor P, Stark J, Beer B, Kostakis E, Gravielle M, Bandyopadhyay S, Russek SJ, Gibbs TT, Farb DH, Skolnick P. (2005). Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator. Proc Natl Acad Sci USA 102:7380–7385.
- Löw K, Crestani F, Keist R, Benke D, Brünig I, Benson JA, Fritschy JM, Rülicke T, Bluethmann H, Möhler H, Rudolph U. (2000). Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131–134.
- McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ. (2000). Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 3:587–592.
- Nakata H, Sakurai H, Yoshizumi H, Tatematsu A. (1968). The primary fragmentation step of isoxazole upon electron impact: a correlation with photochemistry. Org Mass Spectrom 1:199–204.
- Nutt DJ. (2005). Overview of diagnosis and drug treatments of anxiety disorders. CNS Spectr 10:49–56.
- Rudolph U, Crestani F, Benke D, Brünig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Möhler H. (1999). Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401:796–800.
- Sieghart W, Sperk G. (2002). Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem 2:795–816.
- Stewart SH, Westra HA. (2002). Benzodiazepine side-effects: from the bench to the clinic. Curr Pharm Des 8:1–3.